Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Opioid Litigation Settlements topic
No spam. Unsubscribe anytime.
Attorney General’s office: Purdue settlement and smaller manufacturer agreements will bring multi‑year funds, naloxone component expected
Summary
Chris from the Kansas Attorney General’s office told the Sunflower board the Purdue bankruptcy/settlement plans are expected to bring more than $30 million to Kansas over roughly 15 years and that a package of smaller secondary manufacturer settlements could add about $5 million and product (naloxone) components.
Chris, an attorney with the Attorney General’s office, told the board the Purdue bankruptcy resolution and complementary state settlement arrangements are expected to deliver “north of $30,000,000 for Kansas over, about 15 years.” He cautioned that timing and exact amounts depend on court approvals and prepayment options tied to bankruptcy processes. “Don’t expect money out of that likely this year,” Chris said, adding that an initial payment, if it occurs, would probably be late in the year.
Chris also described a package of eight smaller “secondary manufacturer” settlements that together would yield about $5,000,000 for Kansas on varying schedules. He said the smaller package includes a product component similar to the Teva agreement that could add naloxone for the state naloxone program. “We will be working through how to properly distribute that,” he said, and noted nothing was finalized.
Looking at total recovery: Chris told the board that, combining the Purdue resolution, prior Kroger settlement and the newer manufacturer settlements, his projection is that Kansas will cross roughly $400,000,000 in total recoveries; he said he will provide a finalized projection when available.
Bankruptcy and creditor priority questions
Board members asked how the state’s claims would fare if a company that agreed to a settlement later entered bankruptcy. Chris said it depends on settlement terms; some agreements include prepayment rights or other protections. He cited the Endo bankruptcy as an example where the state negotiated a short‑term payment arrangement to maximize recovery rather than relying on prolonged restructuring.
Distribution and program impacts
Chris said the naloxone product component being discussed in the smaller settlements would likely be distributed through the state naloxone program, using an approach similar to processes used after the Teva settlement, but emphasized details are still under review.
No vote or formal action was taken on the settlement updates; the Attorney General’s office said it will continue work with subdivisions and finalize projections and distribution plans when court approvals and administrative steps are complete.
